Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Unraveling complexity. Harnessing insights.
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
We are a clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated companion diagnostic (CDx) and therapeutic (Rx) strategy that leverages our CELsignia CDx platform. CELsignia is uniquely able to analyze live patient tumor cells to identify new groups of cancer patients likely to benefit from targeted therapies.